Unlock instant, AI-driven research and patent intelligence for your innovation.

Antibody targeting interleukin 17a, preparation method and application thereof

A technology of antibodies and antibody drugs, applied in the field of medicine, can solve problems such as unclear downstream signals

Active Publication Date: 2019-06-25
HUABO BIOPHARM
View PDF1 Cites 0 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

IL-17B was found to bind IL-17RB, but its downstream signaling remains unclear

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Antibody targeting interleukin 17a, preparation method and application thereof
  • Antibody targeting interleukin 17a, preparation method and application thereof
  • Antibody targeting interleukin 17a, preparation method and application thereof

Examples

Experimental program
Comparison scheme
Effect test

preparation example Construction

[0138] Antibody preparation

[0139] Any method suitable for producing monoclonal antibodies can be used to produce the anti-IL-17A antibodies of the present invention. For example, animals can be immunized with linked or naturally occurring IL-17A homodimers or fragments thereof. Suitable immunization methods can be used, including adjuvants, immunostimulants, repeated booster immunizations, and one or more approaches can be used.

[0140] Any suitable form of IL-17 can be used as an immunogen (antigen) to produce non-human antibodies specific to IL-17A and screen the biological activity of the antibodies. The eliciting immunogen can be full-length mature human IL-17A, including natural homodimers, or peptides containing single / multiple epitopes. The immunogen can be used alone or in combination with one or more immunogenicity enhancers known in the art. The immunogen can be purified from natural sources or produced in genetically modified cells. The DNA encoding the immunogen...

Embodiment 1

[0172] Example 1 Anti-human IL-17A mouse monoclonal antibody-preparation method of original antibody

[0173] 1.1 Preparation of hybridoma cells that produce murine monoclonal antibodies

[0174] First, human IL-17A protein was used as the antigen, and BALB / c mice were emulsified with adjuvant for multi-point subcutaneous immunization. The serum titer of the immunized mice was monitored. After reaching the requirements, the spleen cells and myeloma (Sp2 / 0) The cells are fused, and the hybridoma polyclonal cells are obtained after HAT screening.

[0175] 1.2 Indirect ELISA-screening method for hybridoma cells

[0176] Use ELISA detection method to screen out highly specific binding polyclones, carry out monoclonal culture, and then use ELISA method to screen highly specific binding monoclonal cell lines; through HT1080 cells to IL-6 release experiment, screen for cell function The effective monoclonal cell line is then analyzed by Biacore method for affinity and half-life, and finall...

Embodiment 2

[0185] Example 2 Cloning of V-gene sequence of anti-IL-17A antibody

[0186] Based on the 5'RACE technology, the DNA sequence encoding the variable region of the mouse antibody expressed by hybridoma 7D6 / 5H8 was determined. In short, the SMART 5'RACE synthesis kit (TAKARA, No. 634859) was used to prepare gene-specific cDNA for the heavy and light chains according to the manufacturer's instructions. The PCR products were analyzed by agarose gel electrophoresis. The variable regions of both the heavy chain and the light chain are approximately 500 base pairs in size. The amplified PCR product with the appropriate band size obtained from the reaction was cloned into the vector pEASY-Blunt Simple plasmid (Beijing Quanshijin, No. CB111-02), and transformed into Stellar E. coli competent cells (TAKARA, No. 636763) )in. Clones were screened by colony PCR with universal M13 forward or reverse primers, and 2-3 clones from each reaction were selected for DNA sequencing analysis. Use Ex...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

PropertyMeasurementUnit
molecular weightaaaaaaaaaa
affinityaaaaaaaaaa
Login to View More

Abstract

The invention provides an antibody targeting interleukin 17A (IL-17A), its preparation method and application. Specifically, the present invention provides a novel anti-IL-17A monoclonal antibody. The antibody of the present invention can bind IL-17A antigen with high specificity, has high affinity and very low immunogenicity, and is used for the preparation of prevention or treatment of IL-17A-related diseases such as various inflammatory or autoimmune diseases drug.

Description

Technical field [0001] The present invention relates to the field of medicine, in particular to an antibody targeting interleukin 17A (also known as IL-17), its preparation method and application. Background technique [0002] So far, 6 members of the IL-17 family have been discovered: IL-17A (IL-17), IL-17B, IL-17C, IL-17D, IL-17E (IL-25), IL-17F. These interleukin-17 cytokines can bind to corresponding receptors to mediate different inflammatory responses. [0003] IL-17A was originally found to be activated by CD4 + T cell secretion. This type of T cell subset that secretes IL-17A is called Th17 cells. In addition to Th17 cells, cytotoxic CD8 + T cells (Tc17), γδ T cells, natural killer T cells (NKT-17) and B cells can also express IL-17A under certain conditions. Innate immune cells, including monocytes, neutrophils, natural killer cells, and lymphoid tissue-inducible (Lti-like) cells can also produce IL-17A. Recently, in a study on trypanosomal infection, it was found that...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
Patent Type & Authority Patents(China)
IPC IPC(8): C07K16/24C12N5/10A61K39/395A61P29/00A61P37/02A61P17/06A61P19/08A61P19/02A61P25/00G01N33/68
CPCG01N33/6869C07K16/244A61K2039/505C07K2317/56C07K2317/33C07K2317/24C07K2317/92G01N2333/54C07K2317/76A61K2039/54A61K2039/545C07K14/7051C07K2317/565C07K2317/622C07K2319/01
Inventor 朱向阳蔡明清于海佳贾慧峰俞玲
Owner HUABO BIOPHARM